Pfizer has agreed to acquire Array BioPharma for approximately $11.4 billion, the companies said, in a deal intended to expand the buyer’s oncology presence and pipeline—starting with an approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results